About
Technology
Issues
FAQ
Links
Official Page
Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052)
site/software ©
exaly
; All materials licenced under
CC by-SA
.